{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T22:44:23Z","timestamp":1793573063058,"version":"4.5.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T00:00:00Z","timestamp":1634774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T00:00:00Z","timestamp":1634774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s00296-021-05035-7","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T08:03:06Z","timestamp":1634803386000},"page":"1119-1131","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Polymyositis and dermatomyositis: ocular manifestations and potential sight-threatening complications"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7022-2395","authenticated-orcid":false,"given":"Raul E.","family":"Ruiz-Lozano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1241-4043","authenticated-orcid":false,"given":"Fabiola","family":"Velazquez-Valenzuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7719-5956","authenticated-orcid":false,"given":"Mariana","family":"Roman-Zamudio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0707-0584","authenticated-orcid":false,"given":"Salma K.","family":"Andrade-Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1419-2109","authenticated-orcid":false,"given":"Alejandro","family":"Rodriguez-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,21]]},"reference":[{"key":"5035_CR1","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.rdc.2019.07.006","volume":"45","author":"J Vencovsky","year":"2019","unstructured":"Vencovsky J, Alexanderson H, Lundberg IE (2019) Idiopathic inflammatory myopathies. Rheum Dis Clin N Am 45:569\u2013581. https:\/\/doi.org\/10.1016\/j.rdc.2019.07.006","journal-title":"Rheum Dis Clin N Am"},{"key":"5035_CR2","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1002\/mus.24566","volume":"51","author":"AR Findlay","year":"2015","unstructured":"Findlay AR, Goyal NA, Mozaffar T (2015) An overview of polymyositis and dermatomyositis. Muscle Nerve 51:638\u2013656. https:\/\/doi.org\/10.1002\/mus.24566","journal-title":"Muscle Nerve"},{"key":"5035_CR3","first-page":"282","volume":"36","author":"GM Bruce","year":"1938","unstructured":"Bruce GM (1938) Retinitis in dermatomyositis. Trans Am Ophthalmol Soc 36:282\u2013297","journal-title":"Trans Am Ophthalmol Soc"},{"key":"5035_CR4","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1177\/112067210601600220","volume":"16","author":"K Hotta","year":"2006","unstructured":"Hotta K (2006) Choroidopathy with serous retinal detachment in a patient with polymyositis. Eur J Ophthalmol 16:318\u2013325. https:\/\/doi.org\/10.1177\/112067210601600220","journal-title":"Eur J Ophthalmol"},{"key":"5035_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/s0021-5155(99)00187-2","volume":"44","author":"T Matsuo","year":"2000","unstructured":"Matsuo T, Matsuura S, Nakagawa H (2000) Retinopathy in a patient with thrombotic thrombocytopenic purpura complicated by polymyositis. Jpn J Ophthalmol 44:161\u2013164. https:\/\/doi.org\/10.1016\/s0021-5155(99)00187-2","journal-title":"Jpn J Ophthalmol"},{"key":"5035_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/09273940601147653","volume":"15","author":"P Venkatesh","year":"2007","unstructured":"Venkatesh P, Bhaskar VM, Keshavamurthy R, Garg S (2007) Proliferative vascular retinopathy in polymyositis and dermatomyositis with scleroderma (overlap syndrome). Ocul Immunol Inflamm 15:45\u201349. https:\/\/doi.org\/10.1080\/09273940601147653","journal-title":"Ocul Immunol Inflamm"},{"key":"5035_CR7","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1080\/09273948.2018.1547407","volume":"28","author":"Z Griger","year":"2020","unstructured":"Griger Z, Danko K, Bodoki L, Aszalos Z, Nemeth G, Ziad H, Gesztelyi R, Zsuga J, Szodoray P, Kemeny-Beke A (2020) Corneal involvement of patients with polymyositis and dermatomyositis. Ocul Immunol Inflamm 28:58\u201366. https:\/\/doi.org\/10.1080\/09273948.2018.1547407","journal-title":"Ocul Immunol Inflamm"},{"key":"5035_CR8","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1136\/ard.57.8.447","volume":"57","author":"O Backhouse","year":"1998","unstructured":"Backhouse O, Griffiths B, Henderson T, Emery P (1998) Ophthalmic manifestations of dermatomyositis. Ann Rheum Dis 57:447\u2013449. https:\/\/doi.org\/10.1136\/ard.57.8.447","journal-title":"Ann Rheum Dis"},{"key":"5035_CR9","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMc1506827","volume":"373","author":"MC Dalakas","year":"2015","unstructured":"Dalakas MC (2015) Inflammatory muscle diseases. N Engl J Med 373:393\u2013394. https:\/\/doi.org\/10.1056\/NEJMc1506827","journal-title":"N Engl J Med"},{"key":"5035_CR10","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tjarnlund A, Bottai M, Werth VP, Pilkington C, Visser M, Alfredsson L, Amato AA, Barohn RJ, Liang MH, Singh JA, Aggarwal R, Arnardottir S, Chinoy H, Cooper RG, Danko K, Dimachkie MM, Feldman BM, Torre IG, Gordon P, Hayashi T, Katz JD, Kohsaka H, Lachenbruch PA, Lang BA, Li Y, Oddis CV, Olesinska M, Reed AM, Rutkowska-Sak L, Sanner H, Selva-O\u2019Callaghan A, Song YW, Vencovsky J, Ytterberg SR, Miller FW, Rider LG, International Myositis Classification Criteria Project consortium TEr, The Juvenile Dermatomyositis Cohort Biomarker S, Repository (2017) 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis 76:1955\u20131964. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211468","journal-title":"Ann Rheum Dis"},{"key":"5035_CR11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/RHU.0b013e3182a21ba8","volume":"19","author":"J Rosa","year":"2013","unstructured":"Rosa J, Garrot LF, Navarta DA, Saucedo C, Scolnik M, Bedran Z, Garcia MV, Sabelli M, Catoggio LJ, Soriano ER (2013) Incidence and prevalence of polymyositis and dermatomyositis in a health management organization in Buenos Aires. J Clin Rheumatol 19:303\u2013307. https:\/\/doi.org\/10.1097\/RHU.0b013e3182a21ba8","journal-title":"J Clin Rheumatol"},{"key":"5035_CR12","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000001736","author":"M Essouma","year":"2021","unstructured":"Essouma M, Noubiap JJ, Singwe-Ngandeu M, Hachulla E (2021) Epidemiology of idiopathic inflammatory myopathies in Africa: a contemporary systematic review. J Clin Rheumatol. https:\/\/doi.org\/10.1097\/RHU.0000000000001736","journal-title":"J Clin Rheumatol"},{"key":"5035_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2019.100018","volume":"2","author":"SH Yang","year":"2019","unstructured":"Yang SH, Chang C, Lian ZX (2019) Polymyositis and dermatomyositis\u2014challenges in diagnosis and management. J Transl Autoimmun 2:100018. https:\/\/doi.org\/10.1016\/j.jtauto.2019.100018","journal-title":"J Transl Autoimmun"},{"key":"5035_CR14","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/s0140-6736(87)92271-9","volume":"1","author":"NE Bowles","year":"1987","unstructured":"Bowles NE, Dubowitz V, Sewry CA, Archard LC (1987) Dermatomyositis, polymyositis, and Coxsackie-B-virus infection. Lancet 1:1004\u20131007. https:\/\/doi.org\/10.1016\/s0140-6736(87)92271-9","journal-title":"Lancet"},{"key":"5035_CR15","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/path.5309","volume":"249","author":"JF Boehler","year":"2019","unstructured":"Boehler JF, Horn A, Novak JS, Li N, Ghimbovschi S, Lundberg IE, Alexanderson H, Alemo Munters L, Jaiswal JK, Nagaraju K (2019) Mitochondrial dysfunction and role of harakiri in the pathogenesis of myositis. J Pathol 249:215\u2013226. https:\/\/doi.org\/10.1002\/path.5309","journal-title":"J Pathol"},{"key":"5035_CR16","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/BOR.0b013e3283317b31","volume":"21","author":"B De Paepe","year":"2009","unstructured":"De Paepe B, Creus KK, De Bleecker JL (2009) Role of cytokines and chemokines in idiopathic inflammatory myopathies. Curr Opin Rheumatol 21:610\u2013616. https:\/\/doi.org\/10.1097\/BOR.0b013e3283317b31","journal-title":"Curr Opin Rheumatol"},{"key":"5035_CR17","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/00000441-199206000-00012","volume":"303","author":"TL Ellingson","year":"1992","unstructured":"Ellingson TL, Wilske K, Aboulafia DM (1992) Case report: thrombotic thrombocytopenic purpura in a patient with polymyositis: therapeutic importance of early recognition and discussion of pathogenic mechanisms. Am J Med Sci 303:407\u2013410. https:\/\/doi.org\/10.1097\/00000441-199206000-00012","journal-title":"Am J Med Sci"},{"key":"5035_CR18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2169\/internalmedicine.34.24","volume":"34","author":"H Makino","year":"1995","unstructured":"Makino H, Nagake Y, Moriwaki K, Hirakawa S, Katayama T, Yanai H, Takahashi K, Akagi T, Ota Z (1995) Thrombotic thrombocytopenic purpura and myoglobinuric acute renal failure following radiation therapy in a patient with polymyositis and cervical cancer. Intern Med 34:24\u201327. https:\/\/doi.org\/10.2169\/internalmedicine.34.24","journal-title":"Intern Med"},{"key":"5035_CR19","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.2169\/internalmedicine.0512-17","volume":"57","author":"S Yamada","year":"2018","unstructured":"Yamada S, Yamashita H, Nakano M, Hatano H, Sasaki T, Takahashi Y, Kaneko H (2018) Thrombotic microangiopathy with polymyositis\/dermatomyositis: three case reports and a literature review. Intern Med 57:2259\u20132265. https:\/\/doi.org\/10.2169\/internalmedicine.0512-17","journal-title":"Intern Med"},{"key":"5035_CR20","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.18240\/ijo.2020.09.17","volume":"13","author":"Z Griger","year":"2020","unstructured":"Griger Z, Danko K, Nemeth G, Hassan Z, Aszalos Z, Szabo K, Bodoki L, Gesztelyi R, Zsuga J, Szodoray P, Kemeny-Beke A (2020) Anterior segment parameters associated with extramuscular manifestations in polymyositis and dermatomyositis. Int J Ophthalmol 13:1443\u20131450. https:\/\/doi.org\/10.18240\/ijo.2020.09.17","journal-title":"Int J Ophthalmol"},{"key":"5035_CR21","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jtos.2020.09.007","volume":"19","author":"RE Ruiz-Lozano","year":"2020","unstructured":"Ruiz-Lozano RE, Hernandez-Camarena JC, Loya-Garcia D, Merayo-Lloves J, Rodriguez-Garcia A (2020) The molecular basis of neurotrophic keratopathy: diagnostic and therapeutic implications. A review. Ocul Surf 19:224\u2013240. https:\/\/doi.org\/10.1016\/j.jtos.2020.09.007","journal-title":"Ocul Surf"},{"key":"5035_CR22","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/s0161-6420(90)32554-x","volume":"97","author":"JC Kattah","year":"1990","unstructured":"Kattah JC, Zimmerman LE, Kolsky MP, Chrousos G, Chavis R, Jaffe G, Manz HJ (1990) Bilateral orbital involvement in fatal giant cell polymyositis. Ophthalmology 97:520\u2013525. https:\/\/doi.org\/10.1016\/s0161-6420(90)32554-x","journal-title":"Ophthalmology"},{"key":"5035_CR23","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1080\/09546634.2017.1403549","volume":"29","author":"V Isak","year":"2018","unstructured":"Isak V, Jorizzo JL (2018) Recent developments on treatment strategies and the prognosis of dermatomyositis: a review. J Dermatol Treat 29:450\u2013459. https:\/\/doi.org\/10.1080\/09546634.2017.1403549","journal-title":"J Dermatol Treat"},{"key":"5035_CR24","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3109\/09546634.2012.697540","volume":"24","author":"LC Strowd","year":"2013","unstructured":"Strowd LC, Jorizzo JL (2013) Review of dermatomyositis: establishing the diagnosis and treatment algorithm. J Dermatol Treat 24:418\u2013421. https:\/\/doi.org\/10.3109\/09546634.2012.697540","journal-title":"J Dermatol Treat"},{"key":"5035_CR25","doi-asserted-by":"publisher","first-page":"992","DOI":"10.3389\/fimmu.2017.00992","volume":"8","author":"A Aussy","year":"2017","unstructured":"Aussy A, Boyer O, Cordel N (2017) Dermatomyositis and immune-mediated necrotizing myopathies: a window on autoimmunity and cancer. Front Immunol 8:992. https:\/\/doi.org\/10.3389\/fimmu.2017.00992","journal-title":"Front Immunol"},{"key":"5035_CR26","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/mus.23302","volume":"45","author":"DE Furst","year":"2012","unstructured":"Furst DE, Amato AA, Iorga SR, Gajria K, Fernandes AW (2012) Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan. Muscle Nerve 45:676\u2013683. https:\/\/doi.org\/10.1002\/mus.23302","journal-title":"Muscle Nerve"},{"key":"5035_CR27","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3899\/jrheum.140566","volume":"42","author":"Z Yang","year":"2015","unstructured":"Yang Z, Lin F, Qin B, Liang Y, Zhong R (2015) Polymyositis\/dermatomyositis and malignancy risk: a metaanalysis study. J Rheumatol 42:282\u2013291. https:\/\/doi.org\/10.3899\/jrheum.140566","journal-title":"J Rheumatol"},{"key":"5035_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3899\/jrheum.190768","volume":"48","author":"MA Turk","year":"2021","unstructured":"Turk MA, Hayworth JL, Nevskaya T, Pope JE (2021) Ocular manifestations in rheumatoid arthritis, connective tissue disease, and vasculitis: a systematic review and metaanalysis. J Rheumatol 48:25\u201334. https:\/\/doi.org\/10.3899\/jrheum.190768","journal-title":"J Rheumatol"},{"key":"5035_CR29","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jaad.2019.06.1309","volume":"82","author":"ME DeWane","year":"2020","unstructured":"DeWane ME, Waldman R, Lu J (2020) Dermatomyositis: clinical features and pathogenesis. J Am Acad Dermatol 82:267\u2013281. https:\/\/doi.org\/10.1016\/j.jaad.2019.06.1309","journal-title":"J Am Acad Dermatol"},{"key":"5035_CR30","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.clindermatol.2015.11.011","volume":"34","author":"FA Santoro","year":"2016","unstructured":"Santoro FA, Huang J (2016) Ocular involvement in cutaneous connective tissue disease. Clin Dermatol 34:138\u2013145. https:\/\/doi.org\/10.1016\/j.clindermatol.2015.11.011","journal-title":"Clin Dermatol"},{"key":"5035_CR31","first-page":"2498","volume":"32","author":"B Marasini","year":"2005","unstructured":"Marasini B, Cossutta R, Massarotti M (2005) Bilateral ocular myositis as a late complication of dermatomyositis. J Rheumatol 32:2498\u20132499","journal-title":"J Rheumatol"},{"key":"5035_CR32","first-page":"379","volume":"32","author":"P Kokotis","year":"2005","unstructured":"Kokotis P, Theodossiadis P, Bouros C, Sfikakis PP (2005) Bilateral ocular myositis as a late complication of dermatomyositis. J Rheumatol 32:379\u2013381","journal-title":"J Rheumatol"},{"key":"5035_CR33","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1007\/s00415-012-6496-4","volume":"259","author":"S Kono","year":"2012","unstructured":"Kono S, Bunai T, Terada T, Shimoyama K, Konishi T, Shirakawa K, Miyajima H (2012) Subacute progressive ophthalmoplegia associated with dermatomyositis. J Neurol 259:1982\u20131984. https:\/\/doi.org\/10.1007\/s00415-012-6496-4","journal-title":"J Neurol"},{"key":"5035_CR34","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1212\/wnl.23.3.305","volume":"23","author":"JO Susac","year":"1973","unstructured":"Susac JO, Garcia-Mullin R, Glaser JS (1973) Ophthalmoplegia in dermatomyositis. Neurology 23:305\u2013310. https:\/\/doi.org\/10.1212\/wnl.23.3.305","journal-title":"Neurology"},{"key":"5035_CR35","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jdcr.2021.01.035","volume":"10","author":"J Roesler","year":"2021","unstructured":"Roesler J, Jenkins D Jr (2021) Lagophthalmos as a presenting sign in dermatomyositis with muscle involvement limited to the ocular muscles. JAAD Case Rep 10:44\u201346. https:\/\/doi.org\/10.1016\/j.jdcr.2021.01.035","journal-title":"JAAD Case Rep"},{"key":"5035_CR36","doi-asserted-by":"publisher","first-page":"3740","DOI":"10.1167\/iovs.16-19600","volume":"57","author":"AK Schuster","year":"2016","unstructured":"Schuster AK, Pfeiffer N, Nickels S, Schulz A, Hohn R, Wild PS, Binder H, Munzel T, Beutel ME, Vossmerbaeumer U (2016) Distribution of anterior chamber angle width and correlation with age, refraction, and anterior chamber depth-the Gutenberg health study. Invest Ophthalmol Vis Sci 57:3740\u20133746. https:\/\/doi.org\/10.1167\/iovs.16-19600","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5035_CR37","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1097\/j.jcrs.0000000000000341","volume":"46","author":"R Mencucci","year":"2020","unstructured":"Mencucci R, De Vitto C, Cennamo M, Vignapiano R, Buzzi M, Favuzza E (2020) Femtosecond laser-assisted cataract surgery in eyes with shallow anterior chamber depth: comparison with conventional phacoemulsification. J Cataract Refract Surg 46:1604\u20131610. https:\/\/doi.org\/10.1097\/j.jcrs.0000000000000341","journal-title":"J Cataract Refract Surg"},{"key":"5035_CR38","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1002\/art.21378","volume":"52","author":"AV Ramanan","year":"2005","unstructured":"Ramanan AV, Campbell-Webster N, Ota S, Parker S, Tran D, Tyrrell PN, Cameron B, Spiegel L, Schneider R, Laxer RM, Silverman ED, Feldman BM (2005) The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids. Arthritis Rheum 52:3570\u20133578. https:\/\/doi.org\/10.1002\/art.21378","journal-title":"Arthritis Rheum"},{"key":"5035_CR39","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1001\/archopht.1991.01080030026023","volume":"109","author":"S Cohen","year":"1991","unstructured":"Cohen S, Kremer I (1991) Bilateral corneal immune ring opacity in Behcet\u2019s syndrome. Arch Ophthalmol 109:324\u2013325. https:\/\/doi.org\/10.1001\/archopht.1991.01080030026023","journal-title":"Arch Ophthalmol"},{"key":"5035_CR40","first-page":"177","volume":"5","author":"BH Cohen","year":"1985","unstructured":"Cohen BH, Sedwick LA, Burde RM (1985) Retinopathy of dermatomyositis. J Clin Neuroophthalmol 5:177\u2013179","journal-title":"J Clin Neuroophthalmol"},{"key":"5035_CR41","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/rheumatology\/keh040","volume":"43","author":"R Foroozan","year":"2004","unstructured":"Foroozan R (2004) Visual loss from optic neuropathy in dermatomyositis. Rheumatology (Oxford) 43:391\u2013393. https:\/\/doi.org\/10.1093\/rheumatology\/keh040","journal-title":"Rheumatology (Oxford)"},{"key":"5035_CR42","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1093\/rheumatology\/34.12.1179","volume":"34","author":"LM Yeo","year":"1995","unstructured":"Yeo LM, Swaby DS, Situnayake RD, Murray PI (1995) Irreversible visual loss in dermatomyositis. Br J Rheumatol 34:1179\u20131181. https:\/\/doi.org\/10.1093\/rheumatology\/34.12.1179","journal-title":"Br J Rheumatol"},{"key":"5035_CR43","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/j.1365-2230.2007.02447.x","volume":"32","author":"ZH Liu","year":"2007","unstructured":"Liu ZH, Wang XD (2007) Acute-onset adult dermatomyositis presenting with erythroderma and diplopia. Clin Exp Dermatol 32:751\u2013752. https:\/\/doi.org\/10.1111\/j.1365-2230.2007.02447.x","journal-title":"Clin Exp Dermatol"},{"key":"5035_CR44","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","volume":"15","author":"JS Wolffsohn","year":"2017","unstructured":"Wolffsohn JS, Arita R, Chalmers R, Djalilian A, Dogru M, Dumbleton K, Gupta PK, Karpecki P, Lazreg S, Pult H, Sullivan BD, Tomlinson A, Tong L, Villani E, Yoon KC, Jones L, Craig JP (2017) TFOS DEWS II diagnostic methodology report. Ocul Surf 15:539\u2013574. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.001","journal-title":"Ocul Surf"},{"key":"5035_CR45","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ajo.2009.09.013","volume":"149","author":"JP Whitcher","year":"2010","unstructured":"Whitcher JP, Shiboski CH, Shiboski SC, Heidenreich AM, Kitagawa K, Zhang S, Hamann S, Larkin G, McNamara NA, Greenspan JS, Daniels TE, Sjogren\u2019s International Collaborative Clinical Alliance Research G (2010) A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjogren\u2019s Syndrome International Registry. Am J Ophthalmol 149:405\u2013415. https:\/\/doi.org\/10.1016\/j.ajo.2009.09.013","journal-title":"Am J Ophthalmol"},{"key":"5035_CR46","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14600","volume":"34","author":"RE Ruiz-Lozano","year":"2021","unstructured":"Ruiz-Lozano RE, Hernandez-Camarena JC, Roman-Zamudio M, Alcazar-Felix RJ, Davila-Cavazos O, Cardenas-de la Garza JA (2021) Three types of cataract associated with atopic dermatitis and chronic topical corticosteroid use: a case report. Dermatol Ther 34:e14600. https:\/\/doi.org\/10.1111\/dth.14600","journal-title":"Dermatol Ther"},{"key":"5035_CR47","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14029","volume":"33","author":"RE Ruiz-Lozano","year":"2020","unstructured":"Ruiz-Lozano RE, Hernandez-Camarena JC, Garza-Garza LA, Bustamante-Arias A, Colorado-Zavala MF, Cardenas-de la Garza JA (2020) Isotretinoin and the eye: a review for the dermatologist. Dermatol Ther 33:e14029. https:\/\/doi.org\/10.1111\/dth.14029","journal-title":"Dermatol Ther"},{"key":"5035_CR48","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/WNO.0000000000000235","volume":"35","author":"Y Wang","year":"2015","unstructured":"Wang Y, Morgan ML, Espino Barros Palau A, Lee AG, Foroozan R (2015) Dermatomyositis-related nonischemic central retinal vein occlusion. J Neuroophthalmol 35:289\u2013292. https:\/\/doi.org\/10.1097\/WNO.0000000000000235","journal-title":"J Neuroophthalmol"},{"key":"5035_CR49","first-page":"2006","volume":"23","author":"S Migliaresi","year":"1996","unstructured":"Migliaresi S, Ambrosone L, Tirri G (1996) Eye involvement in dermatomyositis\/polymyositis. J Rheumatol 23:2006\u20132007","journal-title":"J Rheumatol"},{"key":"5035_CR50","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/1756-185X.12750","volume":"22","author":"M Sharma","year":"2019","unstructured":"Sharma M, Prashar A, Tuli R, Sharma RK, Mahajan VK (2019) Atypical central retinal artery occlusion: an uncommon cause of retinopathy and visual loss in dermatomyositis. Int J Rheum Dis 22:325\u2013330. https:\/\/doi.org\/10.1111\/1756-185X.12750","journal-title":"Int J Rheum Dis"},{"key":"5035_CR51","volume-title":"Amsler grid","author":"K Tripathy","year":"2021","unstructured":"Tripathy K, Salini B (2021) Amsler grid. StatPearls, Treasure Island"},{"key":"5035_CR52","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s13256-019-2152-2","volume":"13","author":"D Vezzola","year":"2019","unstructured":"Vezzola D, Allegrini D, Romano MR, Pagano L, Montericcio A, Fogagnolo P, Rossetti LM, De Cilla S (2019) Optical coherence tomography angiography in Purtscher-like retinopathy associated with dermatomyositis: a case report. J Med Case Rep 13:206. https:\/\/doi.org\/10.1186\/s13256-019-2152-2","journal-title":"J Med Case Rep"},{"key":"5035_CR53","doi-asserted-by":"publisher","first-page":"112067212199404","DOI":"10.1177\/1120672121994042","volume":"23","author":"H Yu","year":"2021","unstructured":"Yu H, Ma X, Tong N, Zhou Z, Zhang Y (2021) Acute exudative paraneoplastic polymorphous vitelliform maculopathy in a patient with thymoma, myasthenia gravis, and polymyositis. Eur J Ophthalmol 23:1120672121994042. https:\/\/doi.org\/10.1177\/1120672121994042","journal-title":"Eur J Ophthalmol"},{"key":"5035_CR54","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/IJG.0000000000001379","volume":"29","author":"P Ichhpujani","year":"2020","unstructured":"Ichhpujani P, Thakur S, Spaeth GL (2020) Contrast sensitivity and glaucoma. J Glaucoma 29:71\u201375. https:\/\/doi.org\/10.1097\/IJG.0000000000001379","journal-title":"J Glaucoma"},{"key":"5035_CR55","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1136\/bjophthalmol-2014-305223","volume":"99","author":"J Richman","year":"2015","unstructured":"Richman J, Zangalli C, Lu L, Wizov SS, Spaeth E, Spaeth GL (2015) The Spaeth\/Richman contrast sensitivity test (SPARCS): design, reproducibility and ability to identify patients with glaucoma. Br J Ophthalmol 99:16\u201320. https:\/\/doi.org\/10.1136\/bjophthalmol-2014-305223","journal-title":"Br J Ophthalmol"},{"key":"5035_CR56","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1167\/tvst.9.13.39","volume":"9","author":"A Rao","year":"2020","unstructured":"Rao A, Pal A, Mohapatra S (2020) Spaeth\/Richman contrast sensitivity in staging glaucoma. Transl Vis Sci Technol 9:39. https:\/\/doi.org\/10.1167\/tvst.9.13.39","journal-title":"Transl Vis Sci Technol"},{"key":"5035_CR57","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/s0967-5868(02)00271-0","volume":"10","author":"FL Mastaglia","year":"2003","unstructured":"Mastaglia FL, Zilko PJ (2003) Inflammatory myopathies: how to treat the difficult cases. J Clin Neurosci 10:99\u2013101. https:\/\/doi.org\/10.1016\/s0967-5868(02)00271-0","journal-title":"J Clin Neurosci"},{"key":"5035_CR58","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.nmd.2010.03.011","volume":"20","author":"J van de Vlekkert","year":"2010","unstructured":"van de Vlekkert J, Hoogendijk JE, de Haan RJ, Algra A, van der Tweel I, van der Pol WL, Uijtendaal EV, de Visser M, Dexa Myositis T (2010) Oral dexamethasone pulse therapy versus daily prednisolone in sub-acute onset myositis, a randomised clinical trial. Neuromuscul Disord 20:382\u2013389. https:\/\/doi.org\/10.1016\/j.nmd.2010.03.011","journal-title":"Neuromuscul Disord"},{"key":"5035_CR59","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.mayocp.2012.10.017","volume":"88","author":"FC Ernste","year":"2013","unstructured":"Ernste FC, Reed AM (2013) Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations. Mayo Clin Proc 88:83\u2013105. https:\/\/doi.org\/10.1016\/j.mayocp.2012.10.017","journal-title":"Mayo Clin Proc"},{"key":"5035_CR60","doi-asserted-by":"publisher","first-page":"365","DOI":"10.7326\/0003-4819-92-3-365","volume":"92","author":"TW Bunch","year":"1980","unstructured":"Bunch TW, Worthington JW, Combs JJ, Ilstrup DM, Engel AG (1980) Azathioprine with prednisone for polymyositis. A controlled, clinical trial. Ann Intern Med 92:365\u2013369. https:\/\/doi.org\/10.7326\/0003-4819-92-3-365","journal-title":"Ann Intern Med"},{"key":"5035_CR61","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/art.1780240107","volume":"24","author":"TW Bunch","year":"1981","unstructured":"Bunch TW (1981) Prednisone and azathioprine for polymyositis: long-term followup. Arthritis Rheum 24:45\u201348. https:\/\/doi.org\/10.1002\/art.1780240107","journal-title":"Arthritis Rheum"},{"key":"5035_CR62","doi-asserted-by":"publisher","first-page":"182","DOI":"10.7326\/0003-4819-81-2-182","volume":"81","author":"AL Metzger","year":"1974","unstructured":"Metzger AL, Bohan A, Goldberg LS, Bluestone R, Pearson CM (1974) Polymyositis and dermatomyositis: combined methotrexate and corticosteroid therapy. Ann Intern Med 81:182\u2013189. https:\/\/doi.org\/10.7326\/0003-4819-81-2-182","journal-title":"Ann Intern Med"},{"key":"5035_CR63","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/archderm.142.1.65","volume":"142","author":"JC Edge","year":"2006","unstructured":"Edge JC, Outland JD, Dempsey JR, Callen JP (2006) Mycophenolate mofetil as an effective corticosteroid-sparing therapy for recalcitrant dermatomyositis. Arch Dermatol 142:65\u201369. https:\/\/doi.org\/10.1001\/archderm.142.1.65","journal-title":"Arch Dermatol"},{"key":"5035_CR64","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","volume":"329","author":"MC Dalakas","year":"1993","unstructured":"Dalakas MC, Illa I, Dambrosia JM, Soueidan SA, Stein DP, Otero C, Dinsmore ST, McCrosky S (1993) A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 329:1993\u20132000. https:\/\/doi.org\/10.1056\/NEJM199312303292704","journal-title":"N Engl J Med"},{"key":"5035_CR65","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1212\/wnl.51.6_suppl_5.s2","volume":"51","author":"MC Dalakas","year":"1998","unstructured":"Dalakas MC (1998) Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases. Neurology 51:S2-8. https:\/\/doi.org\/10.1212\/wnl.51.6_suppl_5.s2","journal-title":"Neurology"},{"key":"5035_CR66","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/ncpneuro0901","volume":"4","author":"MC Dalakas","year":"2008","unstructured":"Dalakas MC (2008) B cells as therapeutic targets in autoimmune neurological disorders. Nat Clin Pract Neurol 4:557\u2013567. https:\/\/doi.org\/10.1038\/ncpneuro0901","journal-title":"Nat Clin Pract Neurol"},{"key":"5035_CR67","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/art.20849","volume":"52","author":"TD Levine","year":"2005","unstructured":"Levine TD (2005) Rituximab in the treatment of dermatomyositis: an open-label pilot study. Arthritis Rheum 52:601\u2013607. https:\/\/doi.org\/10.1002\/art.20849","journal-title":"Arthritis Rheum"},{"key":"5035_CR68","first-page":"1009","volume":"27","author":"R Rios Fernandez","year":"2009","unstructured":"Rios Fernandez R, Callejas Rubio JL, Sanchez Cano D, Saez Moreno JA, Ortego Centeno N (2009) Rituximab in the treatment of dermatomyositis and other inflammatory myopathies. A report of 4 cases and review of the literature. Clin Exp Rheumatol 27:1009\u20131016","journal-title":"Clin Exp Rheumatol"},{"key":"5035_CR69","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1136\/ard.2007.077974","volume":"67","author":"M Dastmalchi","year":"2008","unstructured":"Dastmalchi M, Grundtman C, Alexanderson H, Mavragani CP, Einarsdottir H, Helmers SB, Elvin K, Crow MK, Nennesmo I, Lundberg IE (2008) A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies. Ann Rheum Dis 67:1670\u20131677. https:\/\/doi.org\/10.1136\/ard.2007.077974","journal-title":"Ann Rheum Dis"},{"key":"5035_CR70","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s11596-008-0523-9","volume":"28","author":"Q Xiao","year":"2008","unstructured":"Xiao Q, Hu Y, Chen F, Chen X (2008) A comparative assessment of the efficacy of carbomer gel and carboxymethyl cellulose containing artificial tears in dry eyes. J Huazhong Univ Sci Technol Med Sci 28:592\u2013595. https:\/\/doi.org\/10.1007\/s11596-008-0523-9","journal-title":"J Huazhong Univ Sci Technol Med Sci"},{"key":"5035_CR71","doi-asserted-by":"publisher","first-page":"9013","DOI":"10.1038\/s41598-017-08534-5","volume":"7","author":"BCH Ang","year":"2017","unstructured":"Ang BCH, Sng JJ, Wang PXH, Htoon HM, Tong LHT (2017) Sodium hyaluronate in the treatment of dry eye syndrome: a systematic review and meta-analysis. Sci Rep 7:9013. https:\/\/doi.org\/10.1038\/s41598-017-08534-5","journal-title":"Sci Rep"},{"key":"5035_CR72","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1097\/ICU.0000000000000048","volume":"25","author":"T Alasil","year":"2014","unstructured":"Alasil T, Waheed NK (2014) Pan retinal photocoagulation for proliferative diabetic retinopathy: pattern scan laser versus argon laser. Curr Opin Ophthalmol 25:164\u2013170. https:\/\/doi.org\/10.1097\/ICU.0000000000000048","journal-title":"Curr Opin Ophthalmol"},{"key":"5035_CR73","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.sjopt.2014.09.001","volume":"29","author":"I Kozak","year":"2015","unstructured":"Kozak I, Luttrull JK (2015) Modern retinal laser therapy. Saudi J Ophthalmol 29:137\u2013146. https:\/\/doi.org\/10.1016\/j.sjopt.2014.09.001","journal-title":"Saudi J Ophthalmol"},{"key":"5035_CR74","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/08820538.2017.1353820","volume":"33","author":"SV Reddy","year":"2018","unstructured":"Reddy SV, Husain D (2018) Panretinal photocoagulation: a review of complications. Semin Ophthalmol 33:83\u201388. https:\/\/doi.org\/10.1080\/08820538.2017.1353820","journal-title":"Semin Ophthalmol"},{"key":"5035_CR75","doi-asserted-by":"publisher","first-page":"4523","DOI":"10.1167\/iovs.08-2055","volume":"49","author":"A Klettner","year":"2008","unstructured":"Klettner A, Roider J (2008) Comparison of bevacizumab, ranibizumab, and pegaptanib in vitro: efficiency and possible additional pathways. Invest Ophthalmol Vis Sci 49:4523\u20134527. https:\/\/doi.org\/10.1167\/iovs.08-2055","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5035_CR76","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/ajd.12292","volume":"56","author":"BS Daniel","year":"2015","unstructured":"Daniel BS, Orchard D (2015) Ocular side-effects of topical corticosteroids: what a dermatologist needs to know. Australas J Dermatol 56:164\u2013169. https:\/\/doi.org\/10.1111\/ajd.12292","journal-title":"Australas J Dermatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-05035-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-021-05035-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-05035-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T16:43:02Z","timestamp":1659112982000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-021-05035-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,21]]},"references-count":76,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["5035"],"URL":"https:\/\/doi.org\/10.1007\/s00296-021-05035-7","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,21]]},"assertion":[{"value":"30 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare neither conflicts of interest nor financial disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors state that no part of this review, including tables and photographs, has been copied or published elsewhere.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}